Comparing COVID-19 Control Model Between Iraq and Iran
DOI:
https://doi.org/10.25079/ukhjss.v5n2y2021.pp58-65Keywords:
COVID-19, containment, lockdown, Iraq, IranAbstract
The coronavirus pandemic has reached almost every country in the world. The pandemic and its response have had several short-term as well as long term impacts on human health, society, economy, and environment. For instance, the severe lockdowns imposed in certain countries have caused a widespread economic and humanitarian crisis. Therefore, it is crucial to draw important lessons from this pandemic to amplify our future preparedness and response capacities to similar situations. In this paper, the response strategies utilized by Iraq and Iran is analyzed with comparison of the impacts and outcomes of each strategy used for controlling the spread of the COVID-19 virus. The results show that travel ban, restrictive containment, and supports from the international community in controlling the spread of the virus had a more positive impact in Iraq compared to Iran.
Downloads
References
Abdi, M. & Mirzaei, R. (2020). Iran without Mandatory Quarantine and with Social Distancing Strategy against Coronavirus Disease. Health Security, 18(3), 257-259. Retrieved from https://www.liebertpub.com/doi/epdf/10.1089/hs.2020.0041.
Eqbali, A. & Rasmussen S.E. (2021). Iran Begins Covid-19 Vaccination Campaign. The Wall Street Journal. Retrieved from https://www.wsj.com/articles/iran-begins-covid-19-vaccination-campaign-11612892912 (accessed 9 February 2021).
Errat, N.A, Sauer L.M & Rutkow L. (2020). An integrative review of the limited evidence on international travel bans as an emerging infectious disease disaster control measure. J Emerge Manage, 18(1), 7-14. doi: 10.5055/jem.2020.0446.
Government of Iraq (2020a). Cabinet discusses measures to contain Covid-19, agrees to extend curfew. Retrieved from https://gds.gov.iq/cabinet-discusses-measures-to-contain-covid-19-agrees-to-extend-curfew/ (accessed 26 Mararch 2020).
Government of Iraq (2020b). Cabinet receives briefing on measures to contain Coronavirus, support for health sector. Retrieved from https://gds.gov.iq/cabinet-receives-briefing-on-measures-to-contain-coronavirus-support-for-heath-sector/ (accessed 26 February 2020).
Government of Iraq (2020c). Covid-19: A molecular testing laboratory opens in Baghdad. Retrieved from https://gds.gov.iq/covid-19-a-molecular-testing-laboratory-opens-in-baghdad/ (accessed 25 March 2020).
Government of Iraq (2020d). Covid-19: Cabinet bans travel to and from several countries, orders closure of restaurants, malls for two weeks. Retrieved from https://gds.gov.iq/covid-19-cabinet-bans-travel-to-and-from-several-countries-orders-closure-of-restaurants-malls-for-two-weeks/ (accessed 23 December 2020).
Government of Iraq (2020e). Covid-19: Higher Committee for Health and National Safety announces new measures. Retrieved from https://gds.gov.iq/covid-19-higher-committee-for-health-and-national-safety-announces-new-measures/ (accessed 7 July 2020).
Government of Iraq (2020f). Covid-19: Iraq’s Higher Committee for Health and National Safety extends curfew. Retrieved from https://gds.gov.iq/covid-19-iraqs-higher-committee-for-health-and-national-safety-extends-curfew/ (accessed 8 April 2020).
Government of Iraq (2021a). Covid-19: Covid-19: Iraq extends travel ban to several new countries. Retrieved from https://gds.gov.iq/covid-19-iraq-extends-travel-ban-to-several-new-countries/ (accessed 14 January 2021).
Government of Iraq (2021b). National Coronavirus vaccination campaign is launched. Retrieved from https://gds.gov.iq/national-coronavirus-vaccination-campaign-is-launched/ (accessed 30 March 2021).
Haidar J.I. (2017). Sanction and Export Deflections: Evidence from Iran. Economic Policy (CEPR), 32(90), 319-355. Retrieved from https://scholar.harvard.edu/haidar/publications/sanctions-and-export-deflection-evidence-iran.
Ministry of Health and Medical Education (2020). Retrieved from http://www.behdasht.gov.ir (accessed 4 May 2020).
Mohammadzadeh, N., Shariary, M., Shirmohammadlou, N. & Lohrasbi, V. (2020). A Glance at the Prevalence of Coronavirus Disease in Iran: Strength and Weaknesses. Infection Control & Hospital Epidemiology, 41(12), 1479-1482. doi: 10.1017/ice.2020.193.
REUTERS (2021). At least 194 countries have started vaccinating against COVID-19. Retrieved from https://graphics.reuters.com/world-coronavirus-tracker-and-maps/vaccination-rollout-and-access/ (accessed 15 May 2021).
USAID (2021). COVID-19 RESPONSE: IRAQ. Retrieved from https://www.usaid.gov/iraq/fact-sheets/covid-19-response (accessed 26 February 2021).
Venkatesan, P. (2020). COVID-19 in Iran: round 2. The Lancet Infectious Diseases, 20(7), pp. 784. doi: https://doi.org/10.1016/S1473-3099(20)30500-4.
Wilson M.E. & Chen L.H (2020). Travelers give wings to novel coronavirus (2019-nCoV). Journal of Travel Medicine, 27(2). doi: 10.1093/jtm/taaa015.
WHO in Iraq (2021). WHO supports COVID-19 response in Kurdistan with allocation of US$ 1 million for medical supplies and materials. Retrieved from http://www.emro.who.int/irq/iraq-news/who-continues-to-support-covid-19-response-in-kurdistan-with-new-allocation-of-us-1-million-for-medical-supplies-and-materials.html (accessed 16 February 2021).
World Health Organization (2020). National capacities review tool for a novel coronavirus. Retrieved from https://www.who.int/publication-detail/national-capacities-tools-for-a-novel-Coronavirus (accessed 4 March 2020).
worldometers (2021a). Iran Coronavirus Cases. Retrieved from https://www.worldometers.info/coronavirus/country/iran/ (accessed 19 April 2021).
worldometers (2021b). Iraq Coronavirus Cases. Retrieved from https://www.worldometers.info/coronavirus/country/iraq/ (accessed 19 April 2021).
Zamirirad, A. (2020). Three Implication of the Corona Crisis in Iran. Stiftung Wissenschaft und Politik. Retrieved from https://www.swp-berlin.org/en/publication/three-implications-of-the-corona-crisis-in-iran.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License [CC BY-NC-ND 4.0] that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
